July 7, 2014. FT Chinese simultaneously released the latest Fortune Magazine’s Global 500 on the night of 2014 July 7th worldwide. Jumping up 89 places comparing with last year, with revenues of 33.27 billion US dollars, Sinopharm ranks the 357th on the list and the 8th among all pharmaceutical enterprises